Journal of Applied Oral Science

Repositório de dados e outros materiais relacionados com artigos em processo de avaliação para publicação ou publicados pelo periódico Journal of Applied Oral Science.

Antes de realizar qualquer depósito, consulte os Termos e condições de uso do repositório SciELO Data.

Repositorio de datos y otros materiales relacionados con artículos en proceso de evaluación para publicación o publicados por la revista Journal of Applied Oral Science .

Antes de realizar cualquier depósito, consulte el Términos y condiciones de uso de SciELO Data.

Data and other materials repository related to articles under evaluation for publication or publicated by the Journal of Applied Oral Science .

Before any deposit, consult the SciELO Data Terms and Conditions of Use.

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

431 to 440 of 720 Results

probands_little sister_PAX9-Exon4-F.ab1 Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants Unknown - 226.3 KB - MD5: 58f73bf295f689869841592d5b27b145 Sanger sequencing result of the proband's little sister of PAX9 exon4(NM_001372076.1).
probands_mother_PAX9-Exon2-F.ab1 Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants Unknown - 237.7 KB - MD5: 34861b4716f5359c8af9980dfe1435d2 Sanger sequencing result of the proband's mother of PAX9 exon2(NM_001372076.1).
probands_mother_PAX9-Exon4-F.ab1 Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants Unknown - 223.2 KB - MD5: 5315d5da6dac2e000a09fd957cc542b3 Sanger sequencing result of the proband's mother of PAX9 exon4(NM_001372076.1).
Suppmentary_Figure.jpg Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants JPEG Image - 201.8 KB - MD5: 465e7252fd717d9a5159f87cb558f207 Proband-s sister(III-2)
Suppmentary_table.xls Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants MS Excel Spreadsheet - 92.0 KB - MD5: 22b8c2fe80952edb3035d4688427be40 PAX9 mutation genotypes and phenotypes
Figure_1.xls Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways MS Excel Spreadsheet - 22.0 KB - MD5: ec22d187f03e00ade73c21297cd9e7c9 Figure 1. Primers sequences used for RT-PCR and RT-qPCR.
Figure_2.jpg Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways JPEG Image - 4.6 MB - MD5: eed36ac30a4f1843c5fa4336ab68af16 Figure 2. Isolation and culture of human gingival fibroblasts (HGFs).(A) The appearance of primary HGFs cultured for 2 days.(B) The appearance of primary HGFs cultured for 4 days.(C) The appearance of primary HGFs cultured for 7 days.(D) The appearance of primary HGFs cultured fo...
Figure_3.jpg Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways JPEG Image - 5.9 MB - MD5: de0869fde45f658ac92b5c4ce00aeb92 Figure 3. Identification of the 2th passage cells from HGFs with immunofluorescent staining.(A-C) The green positive expression of FSP-1 in the cytoplasmof HGFs.(D-F) Keratin is unstained in the cytoplasm.(G-I) The positive staining of vimentin in the cytoplasm of HGFs was red fl...
Figure_4.jpg Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways JPEG Image - 975.3 KB - MD5: 46329664c6f49b2e3d5b260470318045 Figure 4. The content of C5a in the cell supernatant of the different group was measured by ELISA assay. Data represent the mean ± SEM. of three independent experiments. +P < 0.05 vs. the control group. *P < 0.05 vs. the LPS+C5aRA group.
Figure_5.jpg Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways JPEG Image - 936.2 KB - MD5: 5a247c4226aa3dcdf08872097e0104dc Figure 5. Effects of C5aR antagonists on the expression of C5aR and inflammatory factors of LPS-induced HGFs by RT-qPCR and Western blotting.(A) C5aRA inhibited expression of C5aR, TNF-α, IL-1β, and IL-6 mRNA in LPS-stimulated HGFs. (B) C5aR antagonists inhibited expression of C5...

probands_little sister_PAX9-Exon4-F.ab1

Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants

Unknown - 226.3 KB -

Sanger sequencing result of the proband's little sister of PAX9 exon4(NM_001372076.1).

probands_mother_PAX9-Exon2-F.ab1

Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants

Unknown - 237.7 KB -

Sanger sequencing result of the proband's mother of PAX9 exon2(NM_001372076.1).

probands_mother_PAX9-Exon4-F.ab1

Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants

Unknown - 223.2 KB -

Sanger sequencing result of the proband's mother of PAX9 exon4(NM_001372076.1).

Suppmentary_Figure.jpg

Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants

JPEG Image - 201.8 KB -

Proband-s sister(III-2)

Suppmentary_table.xls

Feb 2, 2023 - A novel PAX9 compound heterozygous variant in a Chinese family with non-syndromic oligodontia and genotype-phenotype analysis of PAX9 variants

MS Excel Spreadsheet - 92.0 KB -

PAX9 mutation genotypes and phenotypes

Figure_1.xls

Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways

MS Excel Spreadsheet - 22.0 KB -

Figure 1. Primers sequences used for RT-PCR and RT-qPCR.

Figure_2.jpg

Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways

JPEG Image - 4.6 MB -

Figure 2. Isolation and culture of human gingival fibroblasts (HGFs).(A) The appearance of primary HGFs cultured for 2 days.(B) The appearance of primary HGFs cultured for 4 days.(C) The appearance of primary HGFs cultured for 7 days.(D) The appearance of primary HGFs cultured fo...

Figure_3.jpg

Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways

JPEG Image - 5.9 MB -

Figure 3. Identification of the 2th passage cells from HGFs with immunofluorescent staining.(A-C) The green positive expression of FSP-1 in the cytoplasmof HGFs.(D-F) Keratin is unstained in the cytoplasm.(G-I) The positive staining of vimentin in the cytoplasm of HGFs was red fl...

Figure_4.jpg

Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways

JPEG Image - 975.3 KB -

Figure 4. The content of C5a in the cell supernatant of the different group was measured by ELISA assay. Data represent the mean ± SEM. of three independent experiments. +P < 0.05 vs. the control group. *P < 0.05 vs. the LPS+C5aRA group.

Figure_5.jpg

Jan 2, 2023 - C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways

JPEG Image - 936.2 KB -

Figure 5. Effects of C5aR antagonists on the expression of C5aR and inflammatory factors of LPS-induced HGFs by RT-qPCR and Western blotting.(A) C5aRA inhibited expression of C5aR, TNF-α, IL-1β, and IL-6 mRNA in LPS-stimulated HGFs. (B) C5aR antagonists inhibited expression of C5...

Add Data

Share Dataverse

Link Dataverse

Reset Modifications